
🇮🇳|🇺🇸| Post-Doctoral Associate in the Zaidi lab @UMNews via @HGEN_UChicago | Human pop gen & aDNA 🧬| She/Her 👩💻
Minneapolis
Joined May 2019
- Tweets737
- Following383
- Followers313
- Likes2.4K
Pinned Tweet
✨Thrilled to share that the first chapter of my Ph.D. thesis is NOW OUT in Science Advances (science.org/doi/10.1126/scia…)! ✨🥳🎉 🧬. This couldn't have been possible without the support of everyone involved @MaanasaRaghavan @NirajRai3 @Conydelafc @mootspoints and others.
1/n Delighted to share our newly published work in Science Advances, investigating human genetic histories at the northern frontier of the Himalayas 🧬🏔️: science.org/doi/10.1126/scia…
Esha Bandyopadhyay, Ph.D. retweeted
Identifying adaptive variation in spatially structured populations using low-coverage whole-genome sequencing data
academic.oup.com/mbe/advance…
Esha Bandyopadhyay, Ph.D. retweeted
Almost every paper on polygenic risk scores now reminds us that PRS should be adapted to ancestry. A new @NatureGenet study suggests another important dimension. Age.
The authors studied BMI in 62,276 children across 11 age points from 6 weeks to 8 years. They identified 624 independent signals in the longitudinal analysis. Almost one third did not show the same effect in adults! For 165 signals the association disappeared and for 29 the effect reversed direction.
A striking example is PCSK1. One variant increased BMI at around 8 months but was associated with lower BMI in adults. This fits its biology well because PCSK1 processes multiple hormones and neuropeptides and its role changes across development.
The same pattern was seen with polygenic scores. At 8 to 12 months an age-matched genome-wide PGS explained 10.9% of BMI variance. A PGS trained on adult BMI explained only 1.3%. More than an eightfold difference.
The underlying biology was familiar. The leptin melanocortin pathway was strongly enriched but different genes had different temporal profiles. LEPR and PCSK1 were more important early in life while MC4R POMC and BDNF showed more persistent effects.
Signals were also found near GLP1R and GIPR. Some GLP1R variants acted mainly in early childhood. This is especially interesting because GLP1R is the receptor targeted by semaglutide in Ozempic.
Similar results were seen for rare variants in nearly 480,000 genomes. The authors also found parent-of-origin effects. For example KLF14 acted mainly when the allele was inherited from the mother which fits its known imprinting.
To me, this makes it clear that PRS may need to be adapted not only to ancestry but also to age. The difference can be dramatic. In infancy the right age-specific score explained more BMI variation than score trained in adults. The genome stays the same. Its effects do not.
nature.com/articles/s41588-0…
#GWAS #PRS #adiposity #BMI #snRNA
Esha Bandyopadhyay, Ph.D. retweeted
The prestigious International Congress of Human Genetics (ICHG) is coming to Mexico! Guadalajara, March 1-5, 2027. Home of cultural diversity, good weather, and great science! Submit your abstracts before the deadline of September 17, 2026 🔥
We’re excited to share our latest publication in @NatureComms: “Integrating common and rare variants improves polygenic risk prediction across diverse populations” 🧬🧪🫀
nature.com/articles/s41467-0…
Sincere thanks to Jacob Williams (lead), @AndrewHaoyu (senior), @Tony_Chen6, Xing Hua, @wendyWongSW, Kai Yu, @GENES_PK, and all @uk_biobank + @AllofUsResearch participants whose data made this work possible.
Most polygenic risk score (PRS) models focus on common variants. But rare variants can have larger effects for the people who carry them, and they may explain part of the genetic risk not captured by common-variant PRSs.
To address this, we developed RICE (polygenic Risk predictions Integrating Common and rarE variants), a framework for integrating rare variant signals with common-variant PRSs across ancestries.
RICE provides a unified framework to:
• Build a robust common-variant PRS (RICE-CV) by ensembling existing PRS methods
• Identify rare variant sets independent of RICE-CV using STAARpipeline + functional annotations
• Collapse significant rare variant sets into burden scores
• Train rare-variant PRSs (RICE-RV) with penalized regression
• Combine RICE-CV and RICE-RV in an independent validation set for integrated risk prediction
We evaluated RICE using extensive simulations and sequencing data from @uk_biobank and @AllofUsResearch, up to 740M genetic variants from 361,939 individuals across diverse ancestries and 11 complex traits.
A few key findings:
• RICE-CV consistently improved common-variant PRS performance, with average R² gains of 9.4% over the best alternative method for continuous traits across trait–ancestry combinations.
• Adding rare variants through RICE-RV produced further gains, especially for lipid traits and height.
• For lipid traits, incorporating rare variants increased R² by up to ~11.2% in Europeans and ~60.7% in African ancestry compared with common-variant PRS alone.
• Rare variants also helped identify individuals with extreme lipid profiles that common-variant PRS alone may miss. For HDL cholesterol, 6.3% of individuals in the top phenotype decile had high RICE-RV but low RICE-CV.
• The rare-variant signal was not limited to established high-penetrance lipid genes. RICE-RV captured predictive signal beyond LDLR, APOB, and PCSK9, supporting a broader polygenic rare-variant architecture.
Key takeaway: Integrating common and rare variants can significantly improve genetic risk prediction and risk stratification across populations, while rare variants do not improve every trait equally - their value depends on genetic architecture and available sample size.
The software and tutorial are open source:
RICE package: github.com/jwilliams10/RICE
Tutorial: jwilliams10.github.io/RICE_V…
Manuscript code: github.com/jwilliams10/RareV…
Officially online @NatureComms . Excited to share our method, RICE, a PRS framework that integrates common and rare variants, led by Jacob Williams, co-mentored with
@xihaoli. Check it out here: nature.com/articles/s41467-0….
Esha Bandyopadhyay, Ph.D. retweeted
Was an honor to serve as a reviewer on this amazing paper in @nature reporting gene knockouts in ONE THIRD of all human protein coding genes. Yes you read that right... nature.com/articles/s41586-0…
Esha Bandyopadhyay, Ph.D. retweeted
We are hosting the 2026 edition of the Midwest Population Genetics Meeting at UChicago on August 21 and 22! This is a trainee focused meeting with many opportunities to present!
The abstract deadline for Midwest Popgen 2026 has been extended to June 12! jkreinz.github.io/mwpg2026/
Esha Bandyopadhyay, Ph.D. retweeted
Multiple post-doctoral positions are available in my group!
Human Statistical Genomics
Population Genomics
Complex traits studies (diabetes, cardiometabolic traits)
Data science and methods development projects
See voightlab.com/join for details.
Esha Bandyopadhyay, Ph.D. retweeted
A new review article looking at what ancient DNA tells us about selection from @christiandhuber's group was published today in @NatureGenet
Read it here: nature.com/articles/s41588-0…
Esha Bandyopadhyay, Ph.D. retweeted
The air is full of DNA — here’s what scientists are using it for nature.com/articles/d41586-0…
Esha Bandyopadhyay, Ph.D. retweeted
Beautiful work on population structure in Neanderthals by @Diyendo
pnas.org/doi/full/10.1073/pn…
Esha Bandyopadhyay, Ph.D. retweeted
Check out our new paper! 🧐
A high-coverage Neandertal genome confirms small, isolated populations, Denisovan admixture, and extreme population structure accelerating differentiation, with levels matching the most divergent humans today.
pnas.org/doi/10.1073/pnas.25…
Esha Bandyopadhyay, Ph.D. retweeted
Second time the MX biobank project (mxbiobank.org) gets the cover in a @Nature journal! This time in @NatureMedicine highlighting the work by @BarjonCar on Clinical genetic variation in Mexico. Another amazing cover by @mauguz33! nature.com/nm/volumes/32/iss…
Esha Bandyopadhyay, Ph.D. retweeted
PhD position available in Pleistocene animal genomics, combining cutting-edge deep sequencing and pangenome analysis approaches. Join us! careers.univie.ac.at/en/prae…
Esha Bandyopadhyay, Ph.D. retweeted
Come work with me as a Postdoc in Statistical/Computational Genetics/Bioinformatics at University of Copenhagen. See employment.ku.dk/all-vacanci…
Esha Bandyopadhyay, Ph.D. retweeted
Join us for the next seminar in the Human Palaeosystems in Focus series with Lucy van Dorp: Uncovering the Drivers of Pathogen Evolution from Ancient DNA to Modern Disease. 18 November at 14:00 CET. Learn more and Register here: gea.mpg.de/179333/uncovering…
Esha Bandyopadhyay, Ph.D. retweeted
Excited to share our latest work on the factors that determine what genes we find (and don't find!) in GWAS and burden tests.
We describe a critical concept that we call *specificity*.
Led by Jeff Spence and Hakhamanesh Mostafavi:
How do GWAS and rare variant burden tests rank gene signals?
In new work @Nature with Jeff Spence, @jkpritch, and our wonderful coauthors we find the key factors are what we call Specificity, Length, and Luck!
🧬🧪🧵
nature.com/articles/s41586-0…
Esha Bandyopadhyay, Ph.D. retweeted
Happy to announce our article published in Science Advances on the population history of Himalaya. For the first time, high-quality ancient DNA data have been successfully obtained, marking a significant advance in aDNA research in India. @MaanasaRaghavan
science.org/doi/10.1126/scia…
Esha Bandyopadhyay, Ph.D. retweeted
🦴🧬🦴🧬🦴
Abstract submission is now open for the 1st International Conference on Palaeogenomics!
June 23–26 2026, in Stockholm.
Join researchers from across the field for 4 days and >100 talks (+ posters)!
Submit abstracts here 👉
icp2026.palaeogenomics.org/a…
Deadline: Nov 30































